Dan is an experienced entrepreneur with multiple successful exits. He studied molecular biology at MIT and went on to found start-ups in ecommerce and clinical informatics. His last company, Recombinant Data, was sold to Deloitte after building to $15M annual revenue. He worked as the CTO in the Health Care Life Sciences practice for Deloitte Consulting for 7 years building supporting capabilities in drug development and innovation.

Dr. Cone, Director of the Life Sciences Institute at the University of Michigan, is the founding scientist of Courage. He is a National Academy of Sciences member with a focus in the molecular basis of feeding behaviors. His lab established the key intellectual property for novel uses of melanocortin receptors. Dr. Cone has a track record of translating research into ventures including Northwest Neurologic acquired by Neurocrine Biosciences.